BEN and Skye Inteligencia Announce Formation of Skye Salud, a Sovereign Augmented-Intelligence Healthcare Platform for Mexico

Brand Engagement Network (Nasdaq: BNAI) and Skye Inteligencia announced the formation of Skye Salud, a new Mexican entity to develop a sovereign, Spanish‑language augmented‑intelligence healthcare platform for Mexico.

Rhea-AI Summary

Brand Engagement Network (Nasdaq: BNAI) and Skye Inteligencia announced the formation of Skye Salud, a new Mexican entity to develop a sovereign, Spanish‑language augmented‑intelligence healthcare platform for Mexico.

Skye Salud aims to integrate with existing systems, support clinical workflows and documentation, and improve access across Mexico's healthcare system, which serves >130 million people including over 14 million adults with diabetes. Development is in an early stage with an initial launch expected in Q1 2026, subject to development progress, regulatory alignment and institutional readiness.

Positive

• Platform intended for Mexico’s >130 million population
• Addresses >14 million adults living with diabetes
• Built as secure, Spanish‑language native platform
• Initial launch expected in Q1 2026

Negative

• Skye Salud is in an early development stage
• Launch is subject to development progress and institutional readiness
• Deployment depends on regulatory and technical alignment

Argus Dec 8 session

+7.51% close to close Open Argus

Details

News Market Reaction – BNAI

In the Dec 8 session, BNAI gained 7.51%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +7.5% in the session following this news. A strong positive reaction aligns with man...

Analysis

The stock moved +7.5% in the session following this news. A strong positive reaction aligns with management’s recent push into Latin American government and healthcare markets, including the earlier $5,000,000 SKYE LATAM deal and 35% revenue share structure. However, filings highlight ongoing net losses, very limited cash balances, and reliance on external financing arrangements. Past news has sometimes seen gains fade after upbeat announcements. Investors would need to weigh enthusiasm for Skye Salud’s sovereign healthcare platform against the company’s going‑concern language and financing dependence.

Key Figures

Population served: 130 million people Adults with diabetes: Over 14 million adults Initial launch timing: First quarter of 2026

Population served

130 million people

Mexico’s healthcare system coverage mentioned in Skye Salud announcement

Adults with diabetes

Over 14 million adults

Chronic disease burden cited for Mexico in Skye Salud announcement

Initial launch timing

First quarter of 2026

Expected initial launch of Skye Salud, subject to development and readiness

Historical Context

5 past events · Latest: Dec 02

5 events

1. Dec 02

   Reverse stock split

   24h Move

   -10.7%

   Announced 1-for-10 reverse split to address Nasdaq bid-price compliance.

2. Nov 10

   Licensing partnership

   24h Move

   +28.4%

   Finalized $5M exclusive AI licensing and revenue-share partnership in LATAM.

3. Oct 14

   Earnings update

   24h Move

   -6.9%

   Reported Q2 2025 net income and sharply lower operating expenses.

4. Sep 19

   Board & product news

   24h Move

   -3.2%

   Added medical informatics leader to board and introduced insurance AI agent.

5. Jul 15

   Management change

   24h Move

   +1.2%

   Named Interim CEO and highlighted liability reduction and planned acquisition.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

multimodal AI, augmented-intelligence, paper-based records, clinical workflows, +1 more

5 terms

multimodal AI technical

"a developer of secure and governed multimodal AI systems for regulated industries"

Multimodal AI is a type of artificial intelligence that can understand and process different kinds of information at the same time, such as images, sounds, and text. It’s like a person who can watch a video, read captions, and listen to music all at once, helping machines better understand complex situations and make smarter decisions. This technology matters because it enables more natural and versatile interactions between humans and computers.

augmented-intelligence technical

"developing a sovereign augmented-intelligence platform intended to support the modernization"

Augmented intelligence is technology designed to enhance human decision-making by providing suggestions, analysis, and automation while keeping a person in control—think of it as a knowledgeable co‑pilot that highlights options and risks rather than replacing the pilot. Investors care because these tools can boost productivity, reduce errors, speed research and cut costs, while also changing competitive advantage, regulatory exposure and capital needs for companies that adopt them.

paper-based records technical

"Many facilities rely on paper-based records or fragmented electronic systems"

Physical documents and forms stored on paper—such as contracts, medical charts, financial ledgers, and regulatory filings—kept in folders, binders or filing cabinets rather than in electronic systems. Investors care because paper-based records can slow operations, increase storage and retrieval costs, raise the risk of loss or damage, and make audits and compliance checks harder; like a filing cabinet versus a searchable digital database, they affect efficiency, transparency and risk.

clinical workflows medical

"designed to integrate with existing systems, support clinical workflows, strengthen documentation"

Clinical workflows are the step-by-step sequences of tasks, decisions and tools that health professionals follow to deliver care — like a kitchen recipe or an assembly line that coordinates who does what, when, and with which information. Investors care because smoother, faster and more reliable workflows reduce costs, limit regulatory and safety risks, increase staff productivity, and make healthcare software or devices more valuable and easier to sell or scale.

regulatory regulatory

"in alignment with regulatory, technical, and institutional requirements"

Relating to rules, government agencies, and official approvals that control how companies operate, what products they can sell, and how transactions are reported. For investors, regulatory matters matter because they can change a business’s costs, legal risks, or ability to sell products — like a traffic light that can slow, stop, or clear the flow of a company’s growth and profits. Regulatory actions or changes can therefore affect stock value and investment risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WILMINGTON, Del. and MEXICO CITY, Dec. 8, 2025 /PRNewswire/ -- Brand Engagement Network, Inc. (Nasdaq: BNAI) ("BEN"), a developer of secure and governed multimodal AI systems for regulated industries, and Skye Inteligencia LATAM ("Skye Inteligencia"), a Latin America-focused AI technology company, today announced the formation of Skye Salud, a newly created Mexican entity that will begin developing a sovereign augmented-intelligence platform intended to support the modernization of healthcare delivery across Mexico.

Mexico's healthcare system serves more than 130 million people.  It faces substantial challenges related to chronic disease management, including over 14 million adults living with diabetes, along with widespread hypertension and cardiovascular conditions. Many facilities rely on paper-based records or fragmented electronic systems, creating gaps in care continuity, documentation and operational efficiency.  Skye Salud has been formed to begin addressing these needs by developing modern, secure augmented-intelligence capabilities tailored to Mexico's clinical environment. 

Skye Salud is in the early development stage and will be built as a secure, Spanish-language native platform designed to integrate with existing systems, support clinical workflows, strengthen documentation, and help improve access to care across Mexico's healthcare institutions. Development work will progress in alignment with regulatory, technical, and institutional requirements.

"Mexico represents a significant market opportunity to support healthcare modernization through secure augmented intelligence," said Tyler Luck, Acting CEO of BEN. "Skye Salud aligns with BEN's strategy in regulated industries and will be developed to support ongoing efforts to strengthen clinical infrastructure."

Additional details on partnerships and deployment plans will be provided in upcoming announcements. Initial launch is expected in the first quarter of 2026, subject to development progress and institutional readiness.

ABOUT BRAND ENGAGEMENT NETWORK, INC. (BEN) - Brand Engagement Network, Inc. (BEN) (Nasdaq: BNAI) develops conversational AI agents built for regulated and customer-centric industries. Its proprietary Engagement Language Model (ELM™) with retrieval-augmented generation enables enterprises to deploy multimodal, compliance-first AI across chat, voice, avatar, and digital channels. With 21 issued patents, a growing IP portfolio, and early adoption across life sciences, healthcare, insurance, financial services, hospitality, retail, and automotive, BEN is positioned at the intersection of enterprise AI adoption and rising regulatory demand. For more information, visit www.beninc.ai.

ABOUT SKYE INTELIGENCIA LATAM  - Skye Inteligencia LATAM is a Latin America-focused artificial intelligence technology company dedicated to deploying secure, sovereign AI solutions tailored to the region's regulated industries and public-sector needs. Skye Inteligencia has partnered with BEN to deliver compliant, locally governed AI platforms that address critical infrastructure challenges across the healthcare, government, and enterprise sectors in Latin America.

Forward-Looking Statements: Certain statements in this communication are "forward-looking statements" within the meaning of federal securities laws. They are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect, among other things, BEN's current expectations, assumptions, plans, strategies, and anticipated results. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. There are a number of risks, uncertainties and conditions that may cause BEN's actual results to differ materially from those expressed or implied by these forward-looking statements, including but not limited to the risk factors described in Part I, Item 1A of Risk Factors in BEN's Annual Report on Form 10-K for the year ended December 31, 2024 and the other risk factors identified from time to time in BEN's other filings with the Securities and Exchange Commission (the "SEC").  These forward-looking statements may include words such as "believe," "expect," "anticipate," "estimate," "intend," "plan," "project," "should," "may," "will," "might," "could," "would," or similar expressions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ben-and-skye-inteligencia-announce-formation-of-skye-salud-a-sovereign-augmented-intelligence-healthcare-platform-for-mexico-302635097.html

SOURCE Brand Engagement Network, Inc. (BEN)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Skye Salud and which companies formed it (BNAI)?

Skye Salud is a Mexican entity formed by Brand Engagement Network (Nasdaq: BNAI) and Skye Inteligencia to build a sovereign augmented‑intelligence healthcare platform.

When is Skye Salud expected to launch its platform (BNAI)?

The company expects an initial launch in Q1 2026, subject to development progress and institutional readiness.

How will Skye Salud support Mexico’s healthcare system (BNAI)?

Skye Salud aims to integrate with existing systems, support clinical workflows, strengthen documentation, and help improve access to care.

Is the Skye Salud platform tailored for Spanish speakers (BNAI)?

Yes; it will be developed as a Spanish‑language native platform designed for Mexico’s clinical environment.

What population and clinical needs does Skye Salud target (BNAI)?

The initiative targets Mexico’s healthcare system serving >130 million people and aims to address chronic disease management including >14 million adults with diabetes.

What are the main risks to Skye Salud’s timeline (BNAI)?

Risks include early development status, regulatory and technical alignment needs, and institutional readiness that could delay launch.